NCT02058953View on ClinicalTrials.gov

CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases

CompletedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

August 12, 2014

Primary Completion Date

August 19, 2019

Study Completion Date

August 19, 2019

Conditions
MelanomaBrain Metastases
Interventions
PROCEDURE

Craniotomy scheduled

Resection of affected brain tissue

PROCEDURE

Collection for non-craniotomy

CSF, Blood, biopsy

Trial Locations (3)

15232

University of Pittsburgh Medical Center- Hillman Cancer Center, Pittsburgh

77030

The University of Texas- MD Anderson Cancer Center, Houston

Unknown

Melanoma Institute Australia- Westmead Institute for Cancer Research, Sydney

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Pittsburgh

OTHER

NCT02058953 - CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases | Biotech Hunter | Biotech Hunter